Evidence map›Paper›PMID 42071819›Full record

ArticleMedicine2026

Association between C-reactive protein-triglyceride glucose index and overactive bladder: A population-based study from NHANES 2005-2010 and 2015-2018.

Yifan Shao, Yangyang Mei, Guoyang Zhang, Yu Liu, Yiming Chen, Hao Lu, Dong Xue, Linya Yao, Xingliang Feng, Qianfeng Zhuang

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yifan ShaoDepartment of Urology, Traditional Chinese Medicine Hospital of Kunshan, Affiliated Hospital of Nanjing University of Chinese Medicine, Kunshan, Jiangsu, China.
Yangyang MeiDepartment of Urology, Jiangyin People's Hospital, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, Jiangsu, China.
Guoyang ZhangDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Yu LiuDepartment of Urology, Jiangyin People's Hospital, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, Jiangsu, China.
Yiming ChenDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Hao LuDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Dong XueDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Linya YaoDepartment of Urology, Traditional Chinese Medicine Hospital of Kunshan, Affiliated Hospital of Nanjing University of Chinese Medicine, Kunshan, Jiangsu, China.
Xingliang FengDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Qianfeng ZhuangDepartment of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.ORCID 0000-0001-8368-4329

Funding

Changzhou Municipal Health Commission Major Projects ZD202306, ZD202332Changzhou Sci&Tech Program CJ20245011, CE20235059Nanjing Medical University Changzhou Medical Center Project CMCB202312Youth Research Project Granted by Jiangyin Health Commission Q202401
6 · The paper itself

Abstract

Overactive bladder (OAB) is a common urological condition with significant impacts on quality of life and healthcare burden. Chronic inflammation and insulin resistance have been independently linked to bladder dysfunction. The C-reactive protein-triglyceride glucose index (CTI), a novel composite marker reflecting both inflammatory and metabolic status, may provide additional value in assessing OAB risk, but has not been previously studied in this context. We conducted a cross-sectional analysis using data from National Health and Nutrition Examination Survey 2005-2010 and 2015-2018. OAB was defined based on self-reported symptoms of urgency incontinence and nocturia. CTI was calculated as 0.412 × ln (CRP) + TyG, where TyG = ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. Survey-weighted multivariable logistic regression models were used to assess the association between CTI and OAB. Subgroup, interaction, and generalized additive model analyses were performed to explore potential effect modification and nonlinear trends. Discriminative performance was evaluated using receiver operating characteristic curves. A total of 9390 adults were included. Higher CTI levels were significantly associated with increased odds of OAB. In fully adjusted models, each unit increase in CTI was associated with a 17% higher risk of OAB (OR = 1.17, 95% CI: 1.06-1.28, P = .002). Compared to the lowest CTI quartile, the highest quartile showed a 50% increased risk of OAB (OR = 1.50, 95% CI: 1.17-1.93, P = .002). The association persisted across subgroups, with stronger effects observed in females, younger adults, and participants with lower poverty income ratio. Interaction tests confirmed significant effect modification by age (P for interaction < .001) and socioeconomic status (P = .02). Generalized additive model analysis demonstrated a nonlinear positive trend between CTI and OAB prevalence. In receiver operating characteristic analysis, CTI showed superior discriminative ability (AUC = 0.607) compared to CRP (AUC = 0.588) and TyG (AUC = 0.569). CTI is independently associated with the presence of OAB in a representative US adult population. As a composite marker of metabolic and inflammatory burden, CTI may serve as a useful tool for identifying individuals at elevated risk of OAB, particularly among younger and socioeconomically disadvantaged groups.

Indexed as

Blood GlucoseC-Reactive ProteinTriglyceridesUrinary Bladder, OveractiveAdultAgedBiomarkersCross-Sectional StudiesFemaleHumansMaleMiddle AgedNutrition SurveysRisk FactorsUnited StatesBiomarkersBlood GlucoseC-Reactive ProteinTriglyceridesC-reactive protein-triglyceride glucose indexinflammationinsulin resistanceNHANESoveractive bladder

Identifiers

PMID42071819
PMCPMC13124391

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.